We also demonstrated that FBXO22 was positively correlated with CD31 (angiogenesis marker), HIF-1α and VEGFA expression in xenograft GBM tumors, which proved that FBXO22 accelerated GBM angiogenesis and tumorigenesis. The gene discussed is HIF1A; the disease is glioblastoma.